Phosphatidylserine FDA Food Facility Registration Review for US Importers

U.S. phosphatidylserine projects often slow down on one repeated question: the supplier sent an FDA food facility registration file, so does that mean the product is approved for import and supplier qualification is finished?

The short answer is no. Section 415 of the Federal Food, Drug, and Cosmetic Act and 21 CFR Part 1, Subpart H require many domestic and foreign facilities that manufacture, process, pack, or hold food for U.S. consumption to register with FDA, and FDA says those registrations must be renewed every other year. But 21 CFR 1.242 is equally clear that assigning a registration number means the facility is registered with FDA and does not convey FDA approval or endorsement of the facility or its products.

That distinction matters because procurement, QA, import, and sales teams often use the same file for different questions. Once those assumptions mix together, the approval packet becomes harder to manage than it needs to be.

This article is written for U.S. ingredient importers, distributors, contract manufacturers, supplement brands, procurement managers, QA teams, and regulatory reviewers handling phosphatidylserine. It focuses on document control and import-stage clarity. It does not provide legal advice and it does not make medical treatment claims.

Where Nutranexa is mentioned, only verified site facts are used. The current site identifies the operating company as Shandong Baianrui Biopharmaceutical Co., Ltd., founded in 2013, with a 110,000+ m2 campus and a primary export focus on Europe and North America. It also shows separate product paths for Phosphatidylserine, Soy Phosphatidylserine, and Sunflower Phosphatidylserine, plus specification, COA, packaging, and document-request support through Quality & R&D, Manufacturing, and Contact Sales. Final U.S. approval should still depend on the current controlled files for the exact route, order stage, and importer workflow under review.

The Short Answer Buyers Need First

If a phosphatidylserine supplier shares an FDA food facility registration file, buyers should read it as one facility-level control document, not as a complete U.S. approval packet.

The minimum practical workflow is:

1. Confirm that the registered party is the facility relevant to your quoted supply route.
2. Check that the registration is current enough for the commercial stage you are reviewing.
3. Keep the registration file separate from product-specific files such as the specification, source declaration, and COA path.
4. Identify which U.S. party owns FSVP or the modified dietary-supplement import responsibilities for that phosphatidylserine route.
5. Close the file with a clear go, hold, or escalation note instead of assuming the registration solves every downstream question.

That is the core buyer lesson. Registration matters, but it answers a narrower question than many teams assume.

Why This U.S. Buyer Question Matters

Registration is a facility requirement, not product approval

FDA's current registration guidance states that domestic and foreign facilities that manufacture, process, pack, or hold food for human or animal consumption in the United States generally must register with FDA unless an exemption applies. FDA's current registration page also says registrations that are required must be renewed every other year. Those are important control points, but they are still facility-level controls.

The mistake many buyers make is stopping there. 21 CFR 1.242 says assignment of a registration number means the facility is registered with FDA, but that assignment does not in any way convey FDA approval or endorsement of the facility or its products. FDA also states that it does not issue a certificate of registration or product status for food facilities and does not recognize a private certificate as if FDA had issued it.

For phosphatidylserine buyers, that distinction matters immediately:

This is why the most useful internal sentence is simple: food facility registration is a baseline facility document, not a phosphatidylserine product approval file.

Import review breaks when one file is asked to do every job

Most U.S. approval delays are not caused by the existence of the registration file. They happen because teams ask that file to cover work that belongs somewhere else.

Procurement may want proof that the quoted supplier is real. QA may need route-specific technical files. Import teams may need clarity on FSVP ownership. Contract manufacturers may want to know what controls apply at incoming release. Those are different questions, and the approval packet starts to drift when one registration PDF is circulated as if it answers all of them.

FDA's current food-facility registration page makes this easier to understand because it places registration next to other separate import-related systems and submissions, including prior notice. FDA's FSVP rule page makes the separation even clearer: importers generally must perform risk-based foreign supplier verification activities, and there are modified requirements for some importers of dietary supplements and dietary supplement components. In other words, the U.S. framework already treats facility registration, shipment notice, and importer verification as different controls. Buyers should do the same.

The Five-Part Review Workflow

Confirm who the registered party actually is

Start by answering a basic but often skipped question: whose registration file is this?

FDA's public guidance on registration fees and private businesses says traders and brokers are not required to register if they are acting only as traders or brokers and do not manufacture, process, pack, or hold food. That means a buyer should not assume the commercial counterparty and the registered facility are automatically the same party. In phosphatidylserine sourcing, that distinction can matter if the quoted company is acting as an exporter, trading company, or brand-facing sales entity while the manufacturing, packing, or holding role sits elsewhere.

For a cleaner review, the file should tell you:

• legal entity on the registration-related document
• role in the supply chain
• whether that role matches the quoted phosphatidylserine route
• whether the registered facility is the one relevant to manufacturing, packing, or holding the product for U.S. consumption

If the file does not make that relationship clear, the buyer should hold the review until the commercial and facility roles are mapped correctly. This is especially important when reviewing supplier onboarding or building a downstream distributor document pack. Those workflows move more smoothly when the facility identity is settled early.

Check whether the registration is current and commercially relevant

Once the party is clear, the next question is whether the registration status is current enough for the transaction stage.

FDA's current registration page and 21 CFR 1.230 both make the renewal timing practical: required food-facility registrations must be renewed during each even-numbered year cycle. That means a buyer should not treat an old registration reference as permanent proof of current status. A file that was acceptable in one review cycle may need refresh or reconfirmation in the next, especially if the project is moving from exploratory sourcing to a first commercial order.

This step is not only about dates. It is about commercial relevance. Buyers should ask:

• Is the registration file current enough for the order stage we are in?
• Does it appear tied to the same facility role we are relying on now?
• Has the commercial route changed since the file first entered the approval packet?

Separate registration from product-specific technical files

This is the step that prevents the most confusion. A facility registration file should sit beside the technical packet, not inside it as a substitute.

For phosphatidylserine, the product-specific files still need to answer separate questions:

The registration file does none of that by itself. That is why U.S. teams should avoid replying to customer or internal QA questions with only "the factory is FDA registered." A better response is: the supplier has a food-facility registration reference, and we are separately reviewing the current specification, COA path, source route, and import responsibilities for the quoted phosphatidylserine item.

If your team already uses Phosphatidylserine COA Review: Specification and Certificate Checks Before Approval or Can US Contract Manufacturers Rely on a Phosphatidylserine Supplier COA? as internal guidance, this article should sit earlier in the workflow. It answers the narrower supplier-registration question before incoming release or Part 111 qualification logic takes over.

Identify who owns FSVP or modified dietary-supplement import responsibilities

Once the registration file is separated properly, the importer still needs to identify who owns the U.S. verification responsibilities for the food being imported.

FDA's FSVP final-rule page says importers must perform risk-based foreign supplier verification activities to verify that imported food is produced with the required public-health protections and is not adulterated. The same FDA guidance also explains that the regulation includes modified requirements for importers of dietary supplements and dietary supplement components. 21 CFR 1.511 is the eCFR section that governs those modified dietary-supplement situations.

For phosphatidylserine buyers, the practical point is not to force one universal answer. It is to name the responsible party and route clearly. The review file should identify:

• who the U.S. importer is for the food
• whether the project is relying on standard FSVP or a modified dietary-supplement path
• who is establishing and verifying the relevant specifications
• whether the contract manufacturer, importer, or downstream customer controls the next review stage

This is one of the cleanest ways to keep facility registration in its proper lane. Registration helps identify a facility context. FSVP or modified dietary-supplement responsibilities tell you who is responsible for the importer-side verification framework. Those are connected, but not interchangeable.

Close the file with a go, hold, or escalation decision

The final step is to close the review with a short decision note that others can use.

Use one of these outcomes:

• Go: the registration file is current enough, the relevant party is clear, and the rest of the technical packet can move forward.
• Hold: the registration file exists, but the responsible party, renewal status, or facility relevance is still unclear.
• Escalate: the commercial route changed, the document source is weak, or the importer-side FSVP ownership is not defined well enough to proceed.

Registration questions tend to return later if they are not closed early. The best defense is a short closeout note explaining what the file does prove and what other files remain necessary.

Need a Current U.S. Import Support File?

If your team is still using an FDA registration reference as if it were a complete phosphatidylserine approval packet, stop the file flow and rebuild it around the exact U.S. review stage. Nutranexa's contact page can be used to request the current specification, COA support path, source-route confirmation, packaging references, and the current registration-related support file for the exact phosphatidylserine project under discussion.

The fastest requests usually include the source route, order stage, destination use, and whether the first reviewer is procurement, QA, or importer compliance.

Common Mistakes in Phosphatidylserine Registration Review

The repeated mistakes are usually procedural:

1. Treating a food facility registration reference as if it were product approval.
2. Accepting a private "certificate" presentation without separating it from FDA's actual registration framework.
3. Forgetting that traders and brokers may not be the same party as the relevant registered facility.
4. Letting registration, specification, COA, and source-control discussions collapse into one unsorted file.
5. Failing to identify who owns FSVP or the modified dietary-supplement import responsibilities on the U.S. side.

How Verified Nutranexa Facts Fit This Workflow

For buyers evaluating Nutranexa, the current site supports this review in several practical ways.

The site publicly references an FDA food facility registration document while also organizing buyer paths around product, quality, manufacturing, and contact-based document workflows. That supports the right buyer mindset: registration is one supplier-support file, not the whole approval packet.

The site also keeps general Phosphatidylserine, Soy Phosphatidylserine, and Sunflower Phosphatidylserine on separate product paths and confirms the verified PS commercial baseline of 25 kg MOQ with 25 kg net per drum packaging. Together with the founded-in-2013 and 110,000+ m2 campus facts, that helps buyers tie facility-level review back to the quoted route and shipment format.

Most importantly, Nutranexa's site structure encourages buyers to request controlled files through Quality & R&D and Contact Sales rather than overreading one public document image.

Sources

• FDA: Registration of Food Facilities and Other Submissions
• FDA: Questions and Answers Regarding Food Facility Registration (Seventh Edition)
• FDA: Questions Regarding Whether Food Facilities Are Required to Pay Registration Fees and Private Businesses Claiming or Suggesting an Affiliation with FDA
• FDA: FSMA Final Rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals
• eCFR: 21 CFR 1.225
• eCFR: 21 CFR 1.230
• eCFR: 21 CFR 1.242
• eCFR: 21 CFR 1.511

FAQ

Does FDA food facility registration mean a phosphatidylserine supplier is approved by FDA?

No. 21 CFR 1.242 says assignment of a registration number means the facility is registered with FDA, but it does not convey FDA approval or endorsement of the facility or its products.

Is an FDA food facility registration certificate enough for a U.S. phosphatidylserine import file?

No. Buyers should still review the current specification, COA path, source route, packaging context, and the U.S. party's importer-verification responsibilities for the exact phosphatidylserine item being sourced.

Do traders or brokers need to be the same party as the registered food facility?

Not necessarily. FDA states that traders and brokers are not required to register as food facilities if they are acting only as traders or brokers, so buyers should confirm whether the commercial counterparty and the relevant registered facility are the same or different parties.

How often should buyers reconfirm a food facility registration reference?

At minimum, buyers should reconfirm it whenever the commercial route changes, the order is moving into a new approval stage, or the review cycle crosses into a new even-numbered-year renewal period. Buyers should not assume an old registration file is current forever.

Does food facility registration replace FSVP for imported phosphatidylserine?

No. FDA treats these as separate controls. Importers generally must perform FSVP activities for imported food, although 21 CFR 1.511 provides modified requirements for certain dietary supplement and dietary supplement component situations.

Conclusion

FDA food facility registration matters in U.S. phosphatidylserine sourcing, but it matters for a narrower reason than many buyers assume.

It helps confirm a facility-level regulatory baseline where registration is required. It does not by itself approve the product, qualify the supplier in your own system, replace the technical packet, or eliminate importer-side verification responsibilities. The strongest workflow is therefore simple: map the relevant party, check current status, separate the registration from product-specific files, identify the U.S. verification owner, and close the file with a clear decision.

That approach reduces approval friction because it gives procurement, QA, import teams, and downstream customers the same answer at the same time: registration is important, but it is only one part of a controlled phosphatidylserine approval file.

Contact Sales

Contact Nutranexa to request the current phosphatidylserine specification path, route-specific registration support file, COA context, packaging details, and the commercial identity needed to review a U.S. supplier-approval or import-preparation file correctly.

Recommended next steps

• Review the Phosphatidylserine product page.
• Compare Soy PS and Sunflower PS.
• Check manufacturing proof and Quality & R&D.